Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APOL1 Genetic Testing in African Americans: Exploring Attitudes About Genetic Risk to Improve Comprehensive Kidney Risk Assessment for Patients and Families

NCT05656261 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.

NCT NCT05656261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05656261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APOL1 Genetic Testing in African Americans: Exploring Attitudes About Genetic Risk to Improve Comprehensive Kidney Risk Assessment for Patients and Families
Lead sponsor
St. Louis University
Phase
Observational
Overall status
Recruiting
Start date
January 24, 2019
Completion date
June 30, 2027
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apol1 associated kidney disease, chronic kidney diseases, disparities, genetic predisposition, nephropathy